Pluripotency denotes the flexible capacity of single cells to give rise to all somatic lineages and typically also the germline. Mouse ES cells and post-implantation epiblast-derived stem cells (EpiSC) are widely used pluripotent cell culture systems. These two in vitro stem cell types have divergent characteristics. They are considered as representative of distinct developmental stages, distinguished by using the terms "na€ ıve" and "primed". A binary description is an over-simplification, however. Here, we discuss an intermediate stage of pluripotency that we term "formative". Formative pluripotency features a gene regulatory network switch from the na€ ıve state and comprises capacitation of enhancers, signaling pathways and epigenetic machinery in order to install competence for lineage specification.
Pluripotency in the embryo and in culture
After fertilization and initial rounds of cleavage division, embryos of eutherian mammals form a spherical blastocyst. An outer epithelial layer of cells constitute the trophoblast that will give rise to the placenta (Johnson & Ziomek 1983) . The unspecialized inside cells are called the inner cell mass (ICM). Within the ICM, the pluripotent founder population of the embryo proper then emerges in the form of na€ ıve epiblast cells. A second population also segregates within the mature ICM and forms a layer over the blastocoelic surface of the epiblast. This is the hypoblast, which will form the yolk sac (Rossant 1975; Nichols & Gardner 1984) . In both mouse and human, the embryo implants into the uterus shortly after formation of epiblast and hypoblast, although in other mammals development can proceed further before implantation (Lee & DeMayo 2004) . Epiblast cells undergo morphological transformation, accompanied by dynamic transcriptional and epigenetic changes. They remain pluripotent until the end of gastrulation, however.
The epiblast of the pre-implantation embryo is the source of mouse ES cells (Evans & Kaufman 1981; Martin 1981; Brook & Gardner 1997; Boroviak et al. 2014) . ES cells retain the identity of na€ ıve epiblast and can be re-incorporated fully into normal development if introduced back into the blastocyst (Bradley et al. 1984) . After implantation, however, ES cells can no longer be derived (Boroviak et al. 2014) . Instead, an alternative type of pluripotent stem cell line, named post-implantation epiblast-derived stem cells (EpiSC) can be established using different growth conditions (Brons et al. 2007; Tesar et al. 2007 ). EpiSC do not display the capacity to generate chimeras by blastocyst injection. However, if grafted to post-implantation epiblast (Huang et al. 2012; Mascetti & Pedersen 2015) they can incorporate and show signs of early germ layer differentiation in short-term whole embryo culture.
The different pluripotent characters of ES cells and EpiSC and correspondingly of pre-and post-implantation epiblast, are distinguished by the terms "na€ ıve" and "primed" ).
ES cells and na € ıve pluripotency
Today, mouse ES cells are well understood in terms of signal requirements, gene regulatory network and epigenetic status (Wray et al. 2010; Hackett & Surani 2014; Kinoshita 2015; Atlasi & Stunnenberg 2017) . However, when ES cells were initially established, the culture system was empirical and the underlying molecular regulation obscure. Batches of fetal calf serum had to be screened and co-culture with feeder cells was necessary (Robertson 1997) . The first step towards a defined system was the discovery of leukemia inhibitory factor (LIF) as a cytokine that could replace feeder in supporting ES cell self-renewal (Smith & Hooper 1987; Smith et al. 1988; Williams et al. 1988) . Using LIF, ES cells can be propagated without feeder cells on gelatin-coated plates. Serum/ LIF condition makes ES cell culture simpler and, importantly, maintains the potency for blastocyst chimera formation. However, cells in these cultures are a heterogeneous population in terms of expression of genes such as Rex1, Stella, Nanog, Esrrb and Klf4 (Chambers et al. 2007; Hayashi et al. 2008; Toyooka et al. 2008; van den Berg et al. 2008; Niwa et al. 2009 ). Moreover, expression of these genes fluctuates. Furthermore, ES cells could only be derived from particular inbred mouse strains using either serum and feeders or serum/LIF, and batch-tested serum was still required. Serum brings many unknown and variable factors; thus, the development of serum-free culture was needed to understand how the extrinsic environment supports pluripotency and whether ES cell derivation was a generic feature of pluripotent cells in mouse embryos or an artifact of a particular inbred genetic background.
When ES cells are plated in serum-free medium without LIF, they differentiate predominantly into neurons (Ying et al. 2003b ). This suggests that inhibiting neural fate may support serum-free self-renewal. BMP4 belongs to the TGF-b superfamily of growth factors and is well known to suppress dorsalization/ neuralization in Xenopus embryo (Dale et al. 1992) . Serum-free propagation of ES cells was achieved when BMP4 was added in combination with LIF (Ying et al. 2003a) . BMP4 signaling and downstream induction of Id target genes were shown to be sufficient to suppress differentiation in the presence of LIF.
The entry of ES cells into differentiation is triggered in an autocrine manner by FGF4, which activates the ERK/MAPK pathway (Kunath et al. 2007; Stavridis et al. 2007) . LIF and BMP do not block this pathway but rather restrict it from inducing differentiation. Investigation into the effect of genetically or chemically suppressing FGF/ERK signaling led to the finding that direct blockade of the FGF/ERK pathway combined with partial inhibition of glycogen synthase kinase 3 (Gsk3) enabled ES cell propagation without BMP or even LIF (Burdon et al. 1999; Ying et al. 2008) . The now widely adopted version of this system, called 2i, comprises two selective small molecule inhibitors that target MEK (PD0325921) and Gsk3 (CHIR99021). ES cells cultured in 2i are largely homogeneous in terms of gene expression and morphology, especially if LIF is also provided (Wray et al. 2011) . Moreover, by using 2i and LIF, ES cells can reliably be derived from strains of mice such as C57/Bl6 (Kiyonari et al. 2010) or NOD ) that rarely, if at all, yield stable ES cells in serum/LIF. Finally, 2i enables ES cell derivation for the first time from another rodent species, the rat (Buehr et al. 2008; Li et al. 2008) .
The gene regulatory network that sustains na€ ıve ESC in 2i/LIF has been well-characterized in recent years. In addition to the core pluripotency factors Oct3/4 and Sox2 (Niwa et al. 2000; Masui et al. 2007 ), a notable feature is a set of transcription factors and are expressed in ESC and na€ ıve epiblast but are downregulated in EpiSC and peri-implantation epiblast. Among such factors Nanog, Esrrb, Tfcp2L1, Klf2, Klf4, Gbx2 and Tbx3 have all been demonstrated to contribute functionally to ESC self-renewal (Ivanova et al. 2006; Niwa et al. 2009; Martello et al. 2012 Martello et al. , 2013 Ye et al. 2013 ) and form a highly interconnected network (Dunn et al. 2014; .
Na € ıve epigenome
Mouse ES cells have a larger nuclear/cytoplasm ratio compared with somatic cells and electron microscopy shows ES cells also have less heterochromatin compared with differentiated cells (Niwa 2007) . This suggests that the epigenome of na€ ıve cells is distinct.
The na€ ıve epiblast of the ICM are also characterized by global DNA hypomethylation (Lee et al. 2014 ) which increases rapidly upon implantation. ES cells cultured in the presence of 2i show DNA hypomethylation similar to the ICM (Ficz et al. 2013; Habibi et al. 2013; Leitch et al. 2013) . Surprisingly, ES cells maintained in serum/LIF show similar methylation levels to postimplantation embryos and adult somatic tissues. When transferred from serum/LIF to 2i, hypomethylated status can be dynamically restored .
ES cells in 2i also show a substantial reduction in the level of the histone modification H3K27me3 over genes and promoters. (Marks et al. 2012) . This modification, deposited by the polycomb repressive complex 2 (PRC2), is associated with gene silencing. Some loci feature both H3K27me3 and the H3K4me3 mark which generally designates active promoters. Such dual-marked domains are termed bivalent and are thought to be poised for activation. Bivalent domains are relatively few in 2i ES cells (Marks et al. 2012) as well as in the ICM . Interestingly, they are more abundant in serum/LIF (Azuara et al. 2006; Bernstein et al. 2006) , which may reflect the heterogeneous properties of these cultures.
A particular feature associated with the na€ ıve phase of pluripotency is the presence of two active X chromosomes in female cells. In XX embryos the paternal X is initially inactive (Takagi & Sasaki 1975) , and is ª 2018 Japanese Society of Developmental Biologists reactivated in the na€ ıve epiblast (Mak et al. 2004 ). Subsequently, one of the X chromosomes is randomly inactivated in each cell, a process initiated by the long non-coding RNA, Xist. In common with the na€ ıve epiblast, female ES cells exhibit two active X chromosomes that undergo random inactivation during differentiation (Rastan & Robertson 1985) .
Primed pluripotency
Mouse EpiSC are the archetypal representative of primed pluripotency. They can be derived from embryonic day (E)5.5 to E7.5 embryos (Brons et al. 2007; Tesar et al. 2007; Osorno et al. 2012) , but their gene expression signature is most related to anterior primitive streak cells of the E7.0 gastrula (Kojima et al. 2014) . Propagation of EpiSC relies on stimulation with high levels of activin/Nodal and FGF, very different from the 2i system for mouse ES cells. Significantly, the activin/FGF formula was derived from conditions developed for human ES (hES) culture. Although hES cells are established starting from pre-implantation blastocyst stage embryo cultures (Thomson et al. 1998) , they are now known to share more features with mouse EpiSC than mouse ES cells. Moreover, global transcriptome comparison with the non-human primate cynomolgus have revealed that hES cells are more closely related to primate post-implantation epiblast than pre-implantation stages (Nakamura et al. 2016) .
Mouse EpiSC differ from mouse ES cells in growth factor requirements, gene expression profiles, morphology, metabolism, DNA methylation and X chromosome activation status ). In addition, unlike ES cells, EpiSC show little or no colonization of blastocyst stage embryos, unless they have been genetically modified Masaki et al. 2016) . They can contribute when introduced into stage-matched post-implantation mouse embryos in culture (Huang et al. 2012) . Interestingly, hES cells can also make some contribution to inter-species chimeras with post-implantation stage mouse embryo (Masaki et al. 2015; Mascetti & Pedersen 2015) . However, these post-implantation chimera experiments are performed in whole embryo in vitro culture, which supports only short-term development. It is therefore not possible to assess contributions to organogenesis or functional differentiation.
Mouse EpiSC show variable expression of lineagespecific marker genes such as T/Bra, Sox1 and Sox17 (Tsakiridis et al. 2014) . Heterogeneity is reduced to some extent by preventing Wnt stimulation (Kim et al. 2013; Sumi et al. 2013; Tsakiridis et al. 2014; Kurek et al. 2015; Sugimoto et al. 2015) .
Both Tankyrase inhibitors such as XAV939 or IWR-1, or Porcupine inhibitors such as IWP-2 have been used. Tankyrase destabilizes Axin, a central component of the b-catenin destruction complex (Huang et al. 2009 ). Blocking Tankyrase renders the b-catenin destruction complex more stable and results in suppression of canonical Wnt signaling. On the other hand, Porcupine mediates the lipid modification essential for secretion of all Wnt proteins, so Porcupine inhibition affects production of both canonical and non-canonical Wnt. These inhibitors increase EpiSC stability and derivation efficiency from various mouse strains. This effect can be rationalized on the basis that Wnt play a key role in primitive streak induction (Liu et al. 1999; Biechele et al. 2013) .
EpiSC are considered as canonical primed pluripotent stem cells, related to the regionalized and specified gastrulating epiblast. However, the term "primed" has also been applied indiscriminately to any pluripotent cell that is no longer na€ ıve, in some cases even including ES cells in serum. Such usage is an oversimplification that misrepresents the developmental trajectory of pluripotency and associated sequential network transitions. We suggest that the designation "primed" should be confined to cells that exhibit epigenetic and transcriptional features of specification and are thereby predisposed for a particular lineage. Primed cells are fated (Lawson et al. 1991) but not yet committed, as is evident for gastrula stage epiblast (Beddington 1981 (Beddington , 1982 Tam & Beddington 1987) .
A gap in the pluripotency continuum
Na€ ıve pluripotent cells exist in the mouse embryo from approximately E3.75-4.75 (Boroviak et al. 2014) . Primed pluripotent cells, diagnosed by regionalized expression of lineage specification markers, appear only after E6.0-6.5. What is the character of pluripotency in between?
Upon implantation, na€ ıve epiblast cells begin to polarize and form an epithelium (Bedzhov & Zernicka-Goetz 2014) . They gain DNA methylation (Auclair et al. 2014) and in females one of the X chromosomes starts to be silenced (Mak et al. 2004) . Post-implantation epiblast cells expand prior to gastrulation for 24-30 h in mouse embryo and may remain relatively homogeneous during this period (Mohammed et al. 2017) . They gain expression of transcription factors such as Otx2, Pou3f1 (Oct6) and Sox3 as well as maintaining core pluripotency factors Oct3/4 and Sox2. Notably, however, they completely lose the expression of na€ ıve pluripotency factors that are functionally significant for the ES cell state such as Esrrb, Tfcp2l1, Klf4 and Klf2. Nanog is also downregulated and only re-expressed in the posterior epiblast at ª 2018 Japanese Society of Developmental Biologists the pre-streak stage at approximately E6.0 (Hoffman et al. 2013) . Global gene expression analysis at single cell level during this period reveals a transcriptome that is divergent from both pre-implantation na€ ıve and gastrula stage primed pluripotency (Mohammed et al. 2017) . We hypothesize that events in this window may be essential to capacitate pluripotency. Accordingly we coined the term "formative" to describe this maturation phase of pluripotency Smith 2017) (Fig. 1) .
In vitro, na€ ıve ES cells do not respond to differentiation signals directly following 2i withdrawal . Instead, they need first to exit from na€ ıve pluripotency and to establish a new gene regulatory network. Furthermore, cells that have lost ES cell identity do not immediately upregulate definitive lineage specification markers . These observations are consistent with the hypothesis of a formative period in which lineage competence is acquired.
According to our hypothesis, formative pluripotent cells have exited from na€ ıve pluripotency and are governed by a rewired gene regulatory network and signaling apparatus but remain relatively homogeneous and unspecified. They are expected to be immediately responsive to inductive cues and able to execute lineage specification directly (Fig. 1) .
Formative pluripotency in vitro
The formative period partly overlaps with the time window of competence for PGC specification in the mouse embryo. From E5.5 to E6.75, epiblast cells can respond to cytokines that induce PGC fate (Ohinata et al. 2009 ). Neither earlier nor later epiblast responds efficiently to these cues. This restriction is reflected in the non-responsiveness of both ES cells and EpiSC. However, Hayashi et al. (2011) found that during early differentiation of 2i/LIF ES cells, a transient population is generated that exhibits competence for PGC induction (Hayashi et al. 2011 ). This population shows global transcriptome relatedness to E5.5 epiblast and are referred to as epiblast-like cells (EpiLC). EpiLC are generated from 2i/LIF ES cells by culture with activin A and basic FGF in the presence of 1% serum replacement (KSR). EpiLC are short-lived and heterogeneous, but their properties are consistent with the presence of formative phase cells within the population. Specifically, we hypothesize that competence for somatic lineage specification may arise in parallel with germline competence.
Evidence for a discrete formative phase also comes from analysis of ES cell transition in the absence of exogenous growth factors or serum components. ES cells exit the na€ ıve state asynchronously and a reporter system is required to track transition in individual cells. Rex1 (Zfp42) is a na€ ıve pluripotency marker expressed by na€ ıve ES cells and pre-implantation epiblast (Pelton et al. 2002) . Knock-in of destabilized GFP to the Rex1 locus enables loss of na€ ıve identity to be monitored by downregulation of the fluorescent reporter . At an early point (16 h) after 2i withdrawal, cells remain uniformly Rex1::GFP-positive and can revert to self-renewal very efficiently. By 25 h, however, the GFP expression profile becomes heterogeneous. GFP-high cells are still able to self-renew if restored to 2i/LIF but this ability is effectively lost in GFP-low cells. Importantly, the GFP-low cells can respond directly to inductive condition stimuli for PGC and for the three embryonic germ layers . Newly formed GFP-low cells are thus considered as having entered the formative phase. (Shirane et al. 2016; Kalkan et al. 2017) . EpiLC have also been found to have a distinct H3K27ac profile (Kurimoto et al. 2015) . H3K27ac marks active enhancers and gene ontology analysis indicates enrichment for development and morphogenesis in EpiSC relative to EpiLC.
Finally, global Oct3/4 binding site analysis further indicates that the enhancer landscape changes between na€ ıve ES cells and EpiLC (Buecker et al. 2014) . Notably Otx2 is upregulated in formative cells in vitro and in vivo (Acampora et al. 2016 ) and serves to recruit Oct3/4 to new binding sites (Buecker et al. 2014; Yang et al. 2014 ).
Can we capture a self-renewing formative state in culture?
Several observations may suggest that formative cells may exist in culture. As mentioned above, serum/LIF ES cell culture is heterogeneous. In general, cells that do not exhibit na€ ıve transcription factors in such cultures show increased expression of post-implantation marker genes such as FGF5 or Otx2 (Marks et al. 2012; Acampora et al. 2013; Klein et al. 2015) . Some of these cells express later lineage specification markers corresponding to primed status and a few have downregulated Oct3/4 and are thus no longer pluripotent. Many, however, may reside in the formative phase, prior to priming. Whether such cells can be maintained as a pure population independently of continuous generation from ES cells has not been assessed.
ES cells have also been reported to undergo reversible conversion to an alternative pluripotent phenotype described as early primitive ectoderm-like cell (EPL) by culture in specific conditioned medium (Rathjen et al. 1999) . EPL cells require LIF, but marker expression indicates that they are distinct from both na€ ıve ES cells and primed EpiSC. EPL cells may be induced by Lproline which activates the mammalian target of rapamycin (mTOR) pathway (Washington et al. 2010) . Interestingly, the mTOR pathway plays a role in na€ ıve cell exit (Betschinger et al. 2013 ) and gene knockout resulted in embryonic lethality in early post-implantation (Murakami et al. 2004) . This suggests that the mTOR pathway is important in transition from the na€ ıve to formative phase. We note that EPL cells were reported not to contribute to blastocyst chimeras (Rathjen et al. 1999) .
L-Proline has also been identified by metabolite screening as promoting an intermediate stage of ES cell differentiation (Casalino et al. 2011) . These authors describe L-Pro-induced cells (PiC) generated from ES cells. When expression of miRNA 290 and 302 clusters are monitored by two different fluorescent reporters, both are detected in the E5.5 to E6.5 epiblast. However, if pluripotent stem cell lines are established from these transgenic embryos, only the miR290 reporter is expressed in ES cells and only the miR302 reporter in EpiSC (Parchem et al. 2014) . Interestingly, subpopulations of PiC show co-expression of both clusters (D'Aniello et al. 2017) . PiC are also LIF-dependent, but their relationship to EPL cells is unclear. They are reported to contribute to blastocyst chimeras (Casalino et al. 2011) , although more rigorous analyses are required to exclude the possibility that a fraction of undifferentiated ES cells may persist in the PIC cultures and be responsible for chimera contribution.
Occasional EpiSC isolates show some features anticipated to be of formative pluripotency. GOF18-GFP EpiSC are a particularly interesting case (Han et al. 2010) . These EpiSC harbor a randomly integrated transgene in which GFP is linked to the Oct3/4 18-kb enhancer sequence (Yeom et al. 1996) . Although EpiSC express Oct3/4 protein uniformly, GFP is expressed in only a minor fraction of cells in this line, for unknown reasons. The GFP-positive cells have a different gene expression profile from typical EpiSC and show some similarities to E5.5 epiblast. Furthermore, they are readily reset to the na€ ıve ES cell state in culture, and they can contribute to blastocyst chimeras.
Finally, although conventional human ES cells are generally considered as primed, they can exhibit a hierarchical population structure (Hough et al. 2009 ), It is possible that formative cells may be present in human ESC or human induced pluripotent stem cell cultures, at least in some circumstances.
Thus, previously described culture systems may include cells that approximate to a state of formative pluripotency. However, the key test will be to establish conditions for propagating a well-defined cell population that meets the criteria for distinct gene regulatory network and epigenome status matching the pre-gastrula epiblast and is immediately and homogeneously responsive to lineage induction cues (Smith 2017) .
Conclusion
Here we discuss the concept of formative pluripotency as a bridge between the recognized na€ ıve and primed conditions. These three phases are all transient in early development and the transitions between them occur ª 2018 Japanese Society of Developmental Biologists within a sequence of developmental progression (Fig. 1) . It has been possible to capture na€ ıve and primed pluripotency as self-renewing stem cell states in vitro from rodent embryos (Evans & Kaufman 1981; Martin 1981; Brons et al. 2007; Tesar et al. 2007 ) and more recently also from human (Thomson et al. 1998; Guo et al. 2016) . Compared with rodents, primates have a longer interval between na€ ıve pre-implantation epiblast and primed gastrulating cells. Gene expression analysis of non-human primate, cynomolgus monkey (Macaca fascicularis) embryos suggests that there is a major change at implantation but thereafter the epiblast transcriptome remains relatively stable until gastrulation (Nakamura et al. 2016) . Thus, the formative phase of pluripotency may last several days in primate embryos. It will be of considerable interest to determine whether formative pluripotency can be stably maintained in culture and propagated as a stem cell state with unique features.
